Albert Cheng, Ph.D.

Assistant Professor

Farmington, CT

Engineers and applies artificial DNA and RNA binding proteins to study the genome, epigenome, and transcriptome.

Visit The Cheng Lab

Contact me at: 860-837-2016

Connect with me:

About Albert Cheng, Ph.D.

Albert Cheng obtained his BSc in Biochemistry and MPhil in Biology from Hong Kong University of Science and Technology in 2005 and 2007, respectively. He studied neurotrophin signaling and C. elegans developmental genetics. He then pursued his PhD in Computational & Systems Biology at MIT in the labs of Profs Christopher Burge and Rudolf Jaenisch and worked on various topics on epigenetics, gene regulation and alternative splicing in stem cells, reprogramming, cancer metastasis, erythropoiesis and differentiation. Cheng and colleagues identified H3K27ac as a signature for active enhancers. He analyzed alternative splicing in epithetlial-mesenchymal transition, cancer metastasis as well as erythropoiesis and identified splicing factors regulating these processes. He constructed CRISPR-on, an artificial RNA-guided activator based on CRISPR/Cas. After graduating in 2014, he joined the Jackson Laboratory at Bar Harbor, ME, as one of the first JAX scholars where he continued to work on understanding and improving the CRISPR/Cas technology. In July 2015, he started his own lab as an assistant professor at the Jackson Laboratory for Genomic Medicine campus at Farmington, CT.

Download CV

Press ReleaseJanuary 10, 2018
$3.2 million grant to JAX scientist for epigenetic studies to advance precision medicine
A grant from the National Human Genome Research Institute to JAX Assistant Professor Albert Cheng, Ph.D., will fund the creation of a molecular “toolkit” to explore the effects of epigenetic modifications
Search MagazineMay 06, 2016
Molecular marvels
Albert Cheng, Ph.D., is taking the key attributes of CRISPR/Cas and making it more versatile.
Press ReleaseJune 24, 2015
Albert Cheng, Ph.D., expert in genome editing and gene regulation, joins faculty
One of Cheng’s recent achievements is the development of a new technique to activate multiple genes in mouse or human cells to help scientists understand transcription networks that underlie a variety of human diseases.

Search MagazineMay 16, 2016
Casilio unlocks the potential of CRISPR/Cas9
JAX scientists have modified CRISPR/Cas9 to make it more versatile and useful for researchers. JAX Assistant Professor Albert Cheng explains Casilio.
Press ReleaseJanuary 15, 2016
Casilio gives CRISPR-Cas an upgrade
A new gene regulation and labeling platform dubbed "Casilio" is expanding researchers' ability to study gene function and chromosome structure.

Albert Cheng, Ph.D.

Assistant Professor

About Albert Cheng, Ph.D.

Selected Publications